Oral Solid Dosage Contract Manufacturing Market Size Worth USD 22.62 Billion By 2034 | CAGR: 9.4%

The global oral solid dosage contract manufacturing market size is expected to reach USD 22.62 billion by 2034, according to a new study by Polaris Market Research. The report “Oral Solid Dosage Contract Manufacturing Market Share, Size, Trends, Industry Analysis Report, By Product (Tablets, Capsules, Granules Powder, Others); By Mechanism; By End-User; By Region; Segment Forecast, 2026- 2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Contract manufacturers differentiate themselves by offering unique Oral Solid Dosage (OSD) forms, thanks to ongoing improvements in formulation technology. Furthermore, the OSD contract manufacturing sector is seeing a growth in the use of automation and robotics. This technology integration reduces human error, improves manufacturing precision, and increases overall operational efficiency.

Strong technical competence in pharmaceutical formulation coupled with a dedication to regulatory adherence allows businesses to provide superior services while adjusting to changing industry norms. Bigger Contract Manufacturing Organizations (CMOs) take advantage of economies of scale, which let them invest in cutting-edge technology, negotiate advantageous contracts with suppliers, and provide competitive pricing. Their entire profitability and competitiveness in the market are improved by this strategic approach.

Request a free sample copy or read the full market insights : Oral Solid Dosage Contract Manufacturing Market Report

A significant increase in the use of generic drugs might be attributed to the growing need for affordable healthcare solutions. Generic medications are preferred because of their simple production, durability, and excellent patient compliance, particularly in oral solid dosage forms like tablets and capsules. Progress in the sector is largely due to the wide range of generic medications available in oral solid dose forms.

However, ensuring the continuous and high-quality production of oral solid dosage forms presents a formidable challenge. The maintenance of rigorous quality control standards throughout the manufacturing process is essential but can be intricate. Any shortcomings in quality control have the potential to lead to product recalls, tarnished reputations, and legal consequences, acting as a constraint on the market.

Oral Solid Dosage Contract Manufacturing Market Report Highlights

• North America accounted for 41.20% of the global market revenue in 2025. The region benefits from its established pharmaceutical industry and the growing use of contract manufacturing services.

• Asia-Pacific is expected to witness the fastest growth during the forecast period with 11.80%. Growth in pharmaceutical manufacturing, rising drug production, and increasing use of outsourcing services are supporting the regional market.

• Based on product, the tablets segment held 33.10% of the market revenue in 2025. Tablets are widely used due to their cost-effectiveness, easy manufacturing, and ease of administration.

• Based on mechanism, the controlled release segment held 43.50% of the market revenue in 2025. Controlled release systems help in maintaining the drug levels for a longer time and can reduce the frequency of dosing.

• The oral solid dosage contract manufacturing market is highly competitive and major companies include AbbVie Contract Manufacturing, Aenova Group, Alkem Laboratories Limited, Catalent, Inc., Dr. Reddy's Laboratories, Evonik, Famar, Granules India Limited, Jubilant Pharmova Limited, Lonza, Patheon Pharma Services (Thermo Fisher Scientific), Pfizer CentreOne, Piramal Pharma Solutions, Recipharm AB, and Vetter Pharma.

Where is the Market Headed?

The oral solid dosage contract manufacturing market is shifting toward more flexible and specialized manufacturing services. Contract manufacturers are improving their capabilities for complex formulations, high-potency products and large-scale production. Companies are also focusing on stronger supply chains and faster product launches. To meet the evolving pharmaceutical needs, CDMOs are expanding their development, manufacturing, packaging and quality support services. Outsourcing is expected to continue to be important for future market growth.

What Does the Oral Solid Dosage Contract Manufacturing Market Report Reveal?

• What is the global market size and CAGR for the oral solid dosage contract manufacturing market during the forecast period?
• Who are the key industry players? What is their relative position in terms of competitive positioning?
• What factors are contributing largely to the expansion of the oral solid dosage contract manufacturing market?
• How do different products, such as tablets, capsules, granules, and powders, influence the market landscape?
• How does the market differ in terms of product, mechanism, end user, and geography? Which segment is leading the market?
• What are the opportunities in different regional markets, including North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa?
• What are the emerging technologies and manufacturing trends shaping the oral solid dosage contract manufacturing market?

Polaris Market Research has segmented the Oral Solid Dosage Contract Manufacturing Market report based on product, mechanism, end user, and region:

By Product Outlook (Revenue, USD Billion, 2021–2034)

• Tablets
• Capsules
• Granules
• Powder
• Others

By Mechanism Outlook (Revenue, USD Billion, 2021–2034)

• Controlled Release
• Immediate Release
• Delayed Release

By End-User Outlook (Revenue, USD Billion, 2021–2034)

• SMEs
• Large Enterprises
• Others

By Regional Outlook (Revenue, USD Billion, 2021–2034)

• North America
  • US
  • Canada
• Europe
  • France
  • Germany
  • UK
  • Italy
  • Netherlands
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Malaysia
  • Indonesia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa